Development of Technology of Phytosubstantiation of <i>Silybum marianum</i> L. Fruits as a Component of Complex Therapy of Liver Diseases

Q3 Pharmacology, Toxicology and Pharmaceutics Drug Development and Registration Pub Date : 2023-10-27 DOI:10.33380/2305-2066-2023-12-4-1582
B. A. Peres, A. P. Procyuk, A. B. Zelencova, I. E. Kauhova, M. V. Aroyan, E. K. Novikova
{"title":"Development of Technology of Phytosubstantiation of &lt;i&gt;Silybum marianum&lt;/i&gt; L. Fruits as a Component of Complex Therapy of Liver Diseases","authors":"B. A. Peres, A. P. Procyuk, A. B. Zelencova, I. E. Kauhova, M. V. Aroyan, E. K. Novikova","doi":"10.33380/2305-2066-2023-12-4-1582","DOIUrl":null,"url":null,"abstract":"Introduction. Currently, the problem of liver diseases is widespread among the population, especially non-alcoholic fatty liver disease, as well as medicinal liver lesions. In this regard, there is a need to find new solutions in the development of hepatotropic therapy drugs. In clinical practice, several hepatoprotective agents are often used simultaneously in the form of separate drugs or combinations. The combined use of substances in one finished dosage form (FDF) can provide both an enhancement of a particular pharmacological effect and an expansion of the spectrum of hepatotropic action. Components of plant origin are often introduced into the composition of combined hepatoprotectors. Silybum marianum L. fruits contain at least 2.4 % of the amount of flavolignans in terms of silybin, which causes the hepatoprotective effect of medicines based on them and explains the prospects of using this vegetable raw material in the treatment of liver diseases. Aim. Development of technology for obtaining a dry extract of Silybum marianum L. fruit, enriched with silybin. Materials and methods. The objects of the study were Silybum marianum (L.) Gaertn. fruits from producer 2, harvested in June 2022. The quality indicators of the finished product, a dry extract of Silybum marianum (L.) fruit, were determined by the methods described in the SP XIV ed. Statistical processing of the research results was carried out in accordance with SP XIV ed., Volume I, p. 289, GM.1.1.0013.15 \"Statistical processing of the results of a chemical experiment\". Results and discussion. The optimal method of extraction of medicinal plant raw materials is proposed, which allows to obtain the highest yield of biologically active substances. A method of purification of ethanol-water extraction after extraction is proposed. The technology of dry extract of Silybum marianum (L.) fruit has been developed. Standardization of the obtained dry extract was carried out. Conclusion. In the course of the study, the technology of dry extract of Silybum marianum (L.) fruit was developed. The quality indicators of phytosubstantiation, dry extract of Silybum marianum (L.) fruits enriched with silybin were determined.","PeriodicalId":36465,"journal":{"name":"Drug Development and Registration","volume":"19 6","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development and Registration","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33380/2305-2066-2023-12-4-1582","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Currently, the problem of liver diseases is widespread among the population, especially non-alcoholic fatty liver disease, as well as medicinal liver lesions. In this regard, there is a need to find new solutions in the development of hepatotropic therapy drugs. In clinical practice, several hepatoprotective agents are often used simultaneously in the form of separate drugs or combinations. The combined use of substances in one finished dosage form (FDF) can provide both an enhancement of a particular pharmacological effect and an expansion of the spectrum of hepatotropic action. Components of plant origin are often introduced into the composition of combined hepatoprotectors. Silybum marianum L. fruits contain at least 2.4 % of the amount of flavolignans in terms of silybin, which causes the hepatoprotective effect of medicines based on them and explains the prospects of using this vegetable raw material in the treatment of liver diseases. Aim. Development of technology for obtaining a dry extract of Silybum marianum L. fruit, enriched with silybin. Materials and methods. The objects of the study were Silybum marianum (L.) Gaertn. fruits from producer 2, harvested in June 2022. The quality indicators of the finished product, a dry extract of Silybum marianum (L.) fruit, were determined by the methods described in the SP XIV ed. Statistical processing of the research results was carried out in accordance with SP XIV ed., Volume I, p. 289, GM.1.1.0013.15 "Statistical processing of the results of a chemical experiment". Results and discussion. The optimal method of extraction of medicinal plant raw materials is proposed, which allows to obtain the highest yield of biologically active substances. A method of purification of ethanol-water extraction after extraction is proposed. The technology of dry extract of Silybum marianum (L.) fruit has been developed. Standardization of the obtained dry extract was carried out. Conclusion. In the course of the study, the technology of dry extract of Silybum marianum (L.) fruit was developed. The quality indicators of phytosubstantiation, dry extract of Silybum marianum (L.) fruits enriched with silybin were determined.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
水飞蓟植物物化技术的发展</i>L.水果在肝脏疾病综合治疗中的作用
介绍。目前,肝脏疾病问题在人群中普遍存在,尤其是非酒精性脂肪性肝病,以及药物性肝脏病变。在这方面,需要在促肝治疗药物的开发中寻找新的解决方案。在临床实践中,几种肝保护药物经常以单独用药或联合用药的形式同时使用。在一种成品剂型(FDF)中联合使用的物质既可以增强特定的药理作用,又可以扩大促肝作用的范围。植物来源的成分经常被引入到联合肝保护剂的组成中。水飞蓟果实中含有至少2.4%的水飞蓟素黄烷素,这使得以它们为基础的药物具有保护肝脏的作用,并说明了利用这种蔬菜原料治疗肝脏疾病的前景。的目标。制备富含水飞蓟宾的水飞蓟果实干提取物的工艺研究。材料和方法。研究对象为水飞蓟(L.)Gaertn。生产商2的果实,于2022年6月收获。成品水飞蓟(L.)果实干提取物的质量指标按照spxiv版中描述的方法进行测定。研究结果的统计处理按照spxiv版,卷一,p. 289, GM.1.1.0013.15“化学实验结果的统计处理”进行。结果和讨论。提出了药用植物原料的最佳提取方法,以获得最高的生物活性物质收率。提出了一种提取后乙醇-水萃取的纯化方法。研究了水飞蓟果实干提取工艺。对得到的干浸出物进行了标准化。结论。在研究过程中,开发了水飞蓟果实干提取工艺。对富含水飞蓟宾的水飞蓟果实的植物物质、干浸出物的质量指标进行了测定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Development and Registration
Drug Development and Registration Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
1.20
自引率
0.00%
发文量
61
审稿时长
8 weeks
期刊最新文献
Medicinal Perspectives of Retinoids (Review) End-to-end Standardization of Original Medicines when Determining Related Impurities Development of Amlodipine Mini-tablets as a Polypill-component for the Personalized Therapy of Arterial Hypertension Composition and Technology Development for Obtaining Amorphous Solid Dispersion of Ebastine by Hot Melt Extrusion to Increase Dissolution Rate Could Bioluminescent Bacteria be Used in the Search for New Plant-derived Antibacterial Substances?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1